SLC2A4 and Insulin resistance: IGFBP2 has also been demonstrated to activate the AMP-activated protein kinase (AMPK) signaling pathway, resulting in intracellular translocation of glucose transporter 4 (GLUT4), stimulating glucose uptake, improving insulin resistance, and subsequently impacting lipid deposition in hepatocytes (21).